CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | SANSONE GUY P Director | Grant or award | +1,652 | $76.04 | $126K | 13,659.36 |
| 2025-11-20 | ROBBINS LARRY Director | Grant or award · Deferred Stock Units | +2,202.79 | $76.04 | $167K | 8,080.29 |
| 2025-11-20 | Norwalk Leslie V Director | Grant or award | +1,652 | $76.04 | $126K | 5,929 |
| 2025-11-20 | Mahoney Michael F Director | Grant or award · Deferred Stock Units | +2,021.96 | $76.04 | $154K | 4,613.4 |
| 2025-11-20 | KIRBY J SCOTT Director | Grant or award | +1,652 | $76.04 | $126K | 12,987 |
| 2025-11-20 | Finucane Anne A. Director | Grant or award | +591 | $76.04 | $45K | 591 |
| 2025-11-20 | Finucane Anne A. Director | Grant or award · Deferred Stock Units | +1,775.38 | $76.04 | $135K | 16,530.06 |
| 2025-11-20 | DECOUDREAUX ALECIA A Director | Grant or award · Deferred Stock Units | +1,652.09 | $76.04 | $126K | 40,053.52 |
| 2025-11-20 | BROWN C DAVID II Director | Grant or award | +1,775 | $76.04 | $135K | 127,772 |
| 2025-11-20 | Balser Jeffrey R. Director | Grant or award | +1,775 | $76.04 | $135K | 13,659 |
| 2025-11-20 | AGUIRRE FERNANDO Director | Grant or award | +1,800 | $76.04 | $137K | 40,950 |
| 2025-08-31 | Shah Prem S EVP and Group President | Shares withheld for taxes | −6,995 | $73.15 | $512K | 60,631.68 |
| 2025-08-31 | Mandadi Tilak EVP, Chief Exp & Tech Officer | Shares withheld for taxes | −12,834 | $73.15 | $939K | 63,952 |
| 2025-08-20 | Finucane Anne A. Director | Sale | −7,500 | $71.02 | $533K | 22,156 |
| 2025-06-05 | SANSONE GUY P Director | Purchase | +1,570 | $63.70 | $100K | 12,007.36 |
| 2025-05-31 | Newman Brian EVP, Chief Financial Officer | Grant or award | +21,861 | $64.04 | $1.4M | 21,861 |
| 2025-05-31 | Newman Brian EVP, Chief Financial Officer | Grant or award · Stock Option | +94,786 | 94,786 | ||
| 2025-05-31 | Compton-Phillips Amy EVP, Chief Medical Officer | Grant or award | +46,845 | $64.04 | $3.0M | 46,845 |
| 2025-05-31 | Compton-Phillips Amy EVP, Chief Medical Officer | Grant or award | +6,246 | $64.04 | $400K | 53,091 |
| 2025-05-31 | Compton-Phillips Amy EVP, Chief Medical Officer | Grant or award · Stock Option | +27,081 | 27,081 |
Page 4 of 15 · 283 trades